Reduced Renal Microvascular Reactivity to Angiotensin II in Diabetic Rats

References

• Anderson S, Brenner B M. Pathogenesis of diabetic glomerulopathy: Hemodynamic considerations. Diabetes/Metab Rev 1988; 4: 163–167
   PubMed Web of Science ®Google Scholar
• Ballermann B J, Skorecki K L, Brenner B M. Induced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am J Physiol 1984; 247: F110–F116
   Google Scholar
• Bank N. Mechanisms of diabetic hyperfiltration. Kidney Int 1991; 40: 792–807
   PubMedGoogle Scholar
• Bank N, Lahorra M AG, Aynedjian H S, Schlondorff D. Vasoregulatory hormones and the hyperfiltration of diabetes. Am J Physiol 1988; 254: F202–F209
   Google Scholar
• Bank N, Lahorra M A, Aynedjian H S. Acute effects of calcium and insulin on hyperfiltration in early diabetes. Am J Physiol 1987; 252: E13–E20
   Google Scholar
• Bjorck S, Aurell M, Bresater L G, Herlitz H, Welin L, Wikstrand J. Renal sensitivity to angiotensin II in Type 1 diabetes. Scand J Urol Nephrol 1990; 24: 267–273
   Google Scholar
• Brown G P, Venuto R C. Angiotensin II receptors in rabbit preglomerular vessels. Am J Physiol 1988; 255: E16–E22
   Google Scholar
• Carmines P, Fleming J T. Control of the renal microvasculature by vasoactive peptides. FASEB J. 1990; 4: 3300–3309
   Google Scholar
• Christiansen J S, Gammelgaard J, Frandsen M, Parving H H. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin dependent diabetes. Diabelologia 1981; 20: 451–456
   PubMed Web of Science ®Google Scholar
• Conger J D, Falk S A. KC1 and angiotensin responses in isolated rat renal arterioles: Effects of diltiazem and low calcium medium. Am J Physiol 1993; 264: F134–F140, Renal, Fluid, Electrolyte Physiol 33
   Google Scholar
• Conger J D, Falk S A, Robinette J B. Angiotensin II-induced changes in smooth muscle calcium in rat renal arterioles. J Am Soc Nephrol 1993; 3: 1792–1803
   PubMedGoogle Scholar
• Cortes P, Dumler F, Goldman J, Levin N W. Relationship between renal function and metabolic alterations in early streptozotocin-induced diabetes in rats. Diabetes 1987; 36: 80–87
   PubMed Web of Science ®Google Scholar
• Craven P A, Caines M A, DeRubertis F R. Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: Relationship to hyperfiltration in early diabetes. Metabolism 1987; 36: 95–103
   PubMed Web of Science ®Google Scholar
• Craven P A, De Rubertis F R. Role for local prostaglandin and thromboxane production in the regulation of glomerular filtration rate in the rat with streptozotocin-induced diabetes. J Lab Clin Med 1989; 113: 674–681
   Google Scholar
• Fioretto P, et al. Impaired response to angiotensin II in Type 1 (insulin-dependent) diabetes mellitus. Role of prostaglandins and sodium-lithium counter transport activity. Diabetologia 1991; 34: 595–603
   Google Scholar
• Fleming J T, Garthoff B, Mayer D, Rosen B, Steinhausen M. Comparison of the effects of antihypertensive drugs on pre- and postglomerular vessels of the hydronephrotic kidney. J Cardiovasc Pharmacol 1987; 10(Suppl. 10)S149–S153
   Google Scholar
• Fleming J T, Parekh N, Steinhausen M. Calcium antagonists preferentially dilate preglomerular vessels of the hydronephrotic kidney. Am J Physiol 1987; 253: F1157–F1163
   PubMed Web of Science ®Google Scholar
• Goldfarb S, Kern E, Simmons D. Role of polyol pathway activation in the pathogenesis of altered glomerular hemodynamic function in experimental diabetes mellitus in the rat. Lessons from animal diabetes. Frontiers in Diabetes Research, E Shafrir, A E Renold. John Libbey & Co. Ltd. 1988; 517–521
   Google Scholar
• Hayashi K, Epstein M, Loutzenhiser R, Forster H. Impaired myogenic responsiveness of the afferent in streptozotocin-induced diabetic rats. J Am Soc Nephrol 1992; 2: 1578–1586
   PubMedGoogle Scholar
• Hostetter T H. Diabetic nephropathy: Metabolic versus hemodynamic considerations. Diabetes Care 1992; 15(9)1205–1215
   Google Scholar
• Hostetter T M, Troy J L, Brenner B M. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981; 19: 410–415
   PubMed Web of Science ®Google Scholar
• Jensen P K, Christiansen J S, Steven K, Parving H H. Strict metabolic control and renal function in the streptozotocin diabetic rat. Kidney Int 1987; 32: 47–51
   Google Scholar
• Jensen P K, Steven K, Blaehr K, Christiansen J S, Parving H H. Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 1986; 29: 490–495
   PubMedGoogle Scholar
• Kazuhisa O, Carmines P K. Increased superoxide activity mitigates the tonic influence of nitric oxide on renal arterioles during diabetic hyperfiltration. J Am Soc Nephrol (Abstract) 1993; 4(3)800
   Google Scholar
• Loutzenhiser R, Hayashi K, Epstein M. Divergent effects of KCl-induced depolarization on afferent and efferent arterioles. Am J Physiol 1989; 257: F561–F564
   PubMed Web of Science ®Google Scholar
• Moel D I, Safirstein R L, McEvoy R C, Hsueh W. Effect of aspirin on experimental diabetic nephropathy. J Lab Clin Med 1987; 110: 300–307
   PubMedGoogle Scholar
• O'Donnell M P, Kasiske B L, Keane W F. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J 1988; 2: 2339–2347
   PubMedGoogle Scholar
• Parving H H, Viberti G C, Keen H, Christiansen J S, Lassen N A. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983; 32: 943–949
   PubMed Web of Science ®Google Scholar
• Reineek H J, Kreisberg J I. Renal vascular response to angiotensin II (AII) in rats with streptozotocin-induced diabetes mellitus (DM). Kidney Int (abstract). 1983; 23: 247A
   Google Scholar
• Ruderman N B, Williamson J R, Brownlee M. Glucose and diabetic vascular disease. FASEB J 1992; 6: 2905–2914
   PubMed Web of Science ®Google Scholar
• Sarubbi D, McGiff J C, Quilley J. Renal vascular responses and eicosanoid release in diabetic rats. Am J Physiol 1989; 257: F762–F768
   PubMed Web of Science ®Google Scholar
• Schambelan M, Blake S, Sraer J, Bens M, Nivez M, Wahbe M. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 1985; 75: 404–412
   Google Scholar
• Schambelan M, Meyer T W, Kaysen G A, Krolewski A S, Noth R H. Diabetic nephropathy: Hemodynamic basis and implications for disease management. Ann Intern Med 1989; 110: 795–813
   Google Scholar
• Steinhausen M, Kucherer H, Parekh Weis N. S, Wiegman D L, Wilheilm K-R. Angiotensin II control of the renal microcirculation: Effect of blockade by saralasin. Kidney Int 1986; 30: 56–61
   Google Scholar
• Steinhausen M, Sterzel R B, Fleming J T, Kuhn R, Weis S. Acute and chronic effects of angiotensin II on the vessels of the split hydronephrotic kidney. Kidney Int 1987; 31(Suppl. 20)S64–S73
   Google Scholar
• Velasquez M T, Kimmel P L, Michaelis IV OE. Animal models of spontaneous diabetic kidney disease. FASEB J 1990; 4: 2850–2859
   PubMed Web of Science ®Google Scholar
• Whiteside C I, Thompson J. The role of angiotensin II in progressive diabetic glomerulopathy in the rat. Endocrinology 1989; 125: 1932–1940
   Google Scholar
• Wilkes B M. Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat. Time course and mechanism. Endocrinology 1987; 120: 1291–1298
   PubMed Web of Science ®Google Scholar
• Wohner H, Nelischer G. Morphometric investigations on renal vessels of streptozotocin-diabetic rats. Virchows Archiv A Pathol Anat 1991; 419: 231–235
   Google Scholar
• Zatz R, Brenner B M. Pathogenesis of diabetic microangiopathy: The hemodynamic view. Am J Med 1986; 80: 443–453
   PubMed Web of Science ®Google Scholar